Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Fleshner

Showing results (111-120 of 266) with videos related to

Pageof 27
Sort By:
European Urology Oncology|May 19, 2019
Advanced Androgen Blockage in Nonmetastatic Castration-resistant Prostate Cancer: An Indirect Comparison of Apalutamide and EnzalutamideChristopher J D Wallis, Thenappan Chandrasekar, Hanan Goldberg, et al.
The Journal of Urology|March 23, 2010
Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitorsDean Sol Elterman, Nathan Lawrentschuk, Emma Guns, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 19, 2009
The effect of nerve-sparing surgery on patient-reported continence post-radical prostatectomyPaul Toren, Shabbir M H Alibhai, Andre Matthew, et al.
Journal of the National Cancer Institute|October 20, 2005
30-day mortality and major complications after radical prostatectomy: influence of age and comorbidityShabbir M H Alibhai, Marc Leach, George Tomlinson, et al.
Journal of the National Cancer Institute|July 16, 2013
Association between metformin use and risk of prostate cancer and its gradeDavid Margel, David Urbach, Lorraine L Lipscombe, et al.
Journal of Cancer Research and Clinical Oncology|January 16, 2007
MYH mutations are rare in prostate cancerEyun-Jung Shin, Edward Chappell, Vaijayanti Pethe, et al.
Analytical and Quantitative Cytology and Histology|January 24, 2009
Thirty-five years of noninvasive bladder carcinoma: a plea for the use of papillary intraurothelial neoplasia as new terminologyTheodorus H Van der Kwast, Alexandre R Zlotta, Neil Fleshner, et al.
Urologic Oncology|February 19, 2018
Understanding how prostate cancer patients value the current treatment options for metastatic castration resistant prostate cancerTarik Benidir, Karen Hersey, Antonio Finelli, et al.
Urology|November 20, 2003
Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristicsHeather Boon, Kathleen Westlake, Moira Stewart, et al.
The Canadian Journal of Urology|June 12, 2022
Time trends for drug specific adverse events in patients on sunitinib; implications for remote monitoringJacob Wise, Raj Tiwari, Sophie O'Halloran, et al.
Pageof 27

Showing results (111-120 of 266) with videos related to

Sort By:
Pageof 27
European Urology Oncology|May 19, 2019
Advanced Androgen Blockage in Nonmetastatic Castration-resistant Prostate Cancer: An Indirect Comparison of Apalutamide and EnzalutamideChristopher J D Wallis, Thenappan Chandrasekar, Hanan Goldberg, et al.
The Journal of Urology|March 23, 2010
Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitorsDean Sol Elterman, Nathan Lawrentschuk, Emma Guns, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 19, 2009
The effect of nerve-sparing surgery on patient-reported continence post-radical prostatectomyPaul Toren, Shabbir M H Alibhai, Andre Matthew, et al.
Journal of the National Cancer Institute|October 20, 2005
30-day mortality and major complications after radical prostatectomy: influence of age and comorbidityShabbir M H Alibhai, Marc Leach, George Tomlinson, et al.
Journal of the National Cancer Institute|July 16, 2013
Association between metformin use and risk of prostate cancer and its gradeDavid Margel, David Urbach, Lorraine L Lipscombe, et al.
Journal of Cancer Research and Clinical Oncology|January 16, 2007
MYH mutations are rare in prostate cancerEyun-Jung Shin, Edward Chappell, Vaijayanti Pethe, et al.
Analytical and Quantitative Cytology and Histology|January 24, 2009
Thirty-five years of noninvasive bladder carcinoma: a plea for the use of papillary intraurothelial neoplasia as new terminologyTheodorus H Van der Kwast, Alexandre R Zlotta, Neil Fleshner, et al.
Urologic Oncology|February 19, 2018
Understanding how prostate cancer patients value the current treatment options for metastatic castration resistant prostate cancerTarik Benidir, Karen Hersey, Antonio Finelli, et al.
Urology|November 20, 2003
Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristicsHeather Boon, Kathleen Westlake, Moira Stewart, et al.
The Canadian Journal of Urology|June 12, 2022
Time trends for drug specific adverse events in patients on sunitinib; implications for remote monitoringJacob Wise, Raj Tiwari, Sophie O'Halloran, et al.
Pageof 27